Liraglutide
Liraglutide (Victoza / Saxenda)
The first GLP-1 receptor agonist approved for weight management. FDA-approved as Victoza for Type 2 diabetes and as Saxenda for chronic weight management. Taken once daily, it paved the way for Semaglutide and Tirzepatide.
FDA-approved medication
Weight Loss
FDA-approved as Saxenda for chronic weight management. Works by reducing appetite, slowing gastric emptying, and triggering satiety signals in the brain.
Blood Sugar Control
FDA-approved as Victoza for Type 2 diabetes. Stimulates glucose-dependent insulin secretion and reduces postmeal blood sugar spikes.
Cardiovascular Protection
The LEADER trial demonstrated a significant reduction in major cardiovascular events in high-risk patients, a landmark result that expanded GLP-1 therapy beyond diabetes.
Not medical advice. Talk to a licensed provider.